Global T-cell Therapy Databank Market Report

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,000	100 Pages	Magna Intelligence	April, 2024	MAIN18750491

Best Price Guarantee
Price	from $2,000
Length	100 Pages
Publisher	Magna Intelligence
Published Date	April, 2024
SKU	MAIN18750491

Global T-cell Therapy Databank Market Report

The T-cell Therapy market was valued at $2,851.6 Million in 2022, and is projected to reach $29,563.2 Million by 2031 growing at a CAGR of 29.88% from 2023 to 2031. Tumor Infiltrating Lymphocytes (TIL)-based segment is expected to be the highest contributor to this market, with $2,191.5 Million in 2022, and is anticipated to reach $21,789.1 Million by 2031, registering a CAGR of 29.27%. CAR T-cell Therapy segment is anticipated to reach $2,551.9 Million by 2031 with the highest CAGR of 34.26%. Tumor Infiltrating Lymphocytes (TIL)-based and T Cell Receptor (TCR)-based segments collectively expected to account for about 93.6% share of the T-cell Therapy market in 2022, with the former constituting around 76.9% share. CAR T-cell Therapy and T Cell Receptor (TCR)-based segments are expected to witness significant growth rates at a CAGR of 34.26% and 30.62% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 23.1% in the overall T-cell Therapy market in 2022, and is anticipated to reach 26.3% by 2031.

1. Global T-cell Therapy Market, By Therapy Type: 1.1. Overview; 1.2. CAR T-cell Therapy; 1.2.1 CAR T-cell Therapy Market, By Region; 1.2.1.1 North America CAR T-cell Therapy Market, By Country; 1.2.1.2 Europe CAR T-cell Therapy Market, By Country; 1.2.1.3 Asia-Pacific CAR T-cell Therapy Market, By Country; 1.2.1.4 Rest of World CAR T-cell Therapy Market, By Country; 1.3. T Cell Receptor (TCR)-based; 1.3.1 T Cell Receptor (TCR)-based Market, By Region; 1.3.1.1 North America T Cell Receptor (TCR)-based Market, By Country; 1.3.1.2 Europe T Cell Receptor (TCR)-based Market, By Country; 1.3.1.3 Asia-Pacific T Cell Receptor (TCR)-based Market, By Country; 1.3.1.4 Rest of World T Cell Receptor (TCR)-based Market, By Country; 1.4. Tumor Infiltrating Lymphocytes (TIL)-based; 1.4.1 Tumor Infiltrating Lymphocytes (TIL)-based Market, By Region; 1.4.1.1 North America Tumor Infiltrating Lymphocytes (TIL)-based Market, By Country; 1.4.1.2 Europe Tumor Infiltrating Lymphocytes (TIL)-based Market, By Country; 1.4.1.3 Asia-Pacific Tumor Infiltrating Lymphocytes (TIL)-based Market, By Country; 1.4.1.4 Rest of World Tumor Infiltrating Lymphocytes (TIL)-based Market, By Country
2. Global T-cell Therapy Market, By Indication: 2.1. Overview; 2.2. Hematologic Malignancies; 2.2.1 Hematologic Malignancies Market, By Region; 2.2.1.1 North America Hematologic Malignancies Market, By Country; 2.2.1.2 Europe Hematologic Malignancies Market, By Country; 2.2.1.3 Asia-Pacific Hematologic Malignancies Market, By Country; 2.2.1.4 Rest of World Hematologic Malignancies Market, By Country; 2.3. Solid Tumors; 2.3.1 Solid Tumors Market, By Region; 2.3.1.1 North America Solid Tumors Market, By Country; 2.3.1.2 Europe Solid Tumors Market, By Country; 2.3.1.3 Asia-Pacific Solid Tumors Market, By Country; 2.3.1.4 Rest of World Solid Tumors Market, By Country; 2.4. Other Indications; 2.4.1 Other Indications Market, By Region; 2.4.1.1 North America Other Indications Market, By Country; 2.4.1.2 Europe Other Indications Market, By Country; 2.4.1.3 Asia-Pacific Other Indications Market, By Country; 2.4.1.4 Rest of World Other Indications Market, By Country
3. Global T-cell Therapy Market, By Region: 3.1. Overview; 3.2. North America; 3.2.1 North America T-cell Therapy Market, By Therapy Type; 3.2.2 North America T-cell Therapy Market, By Indication; 3.2.3 North America T-cell Therapy Market, By Country; 3.2.3.1 U.S.; 3.2.3.1.1 U.S. T-cell Therapy Market, By Therapy Type; 3.2.3.1.2 U.S. T-cell Therapy Market, By Indication; 3.2.3.2 Canada; 3.2.3.2.1 Canada T-cell Therapy Market, By Therapy Type; 3.2.3.2.2 Canada T-cell Therapy Market, By Indication; 3.3. Europe; 3.3.1 Europe T-cell Therapy Market, By Therapy Type; 3.3.2 Europe T-cell Therapy Market, By Indication; 3.3.3 Europe T-cell Therapy Market, By Country; 3.3.3.1 Germany; 3.3.3.1.1 Germany T-cell Therapy Market, By Therapy Type; 3.3.3.1.2 Germany T-cell Therapy Market, By Indication; 3.3.3.2 U.K.; 3.3.3.2.1 U.K. T-cell Therapy Market, By Therapy Type; 3.3.3.2.2 U.K. T-cell Therapy Market, By Indication; 3.3.3.3 France; 3.3.3.3.1 France T-cell Therapy Market, By Therapy Type; 3.3.3.3.2 France T-cell Therapy Market, By Indication; 3.3.3.4 Italy; 3.3.3.4.1 Italy T-cell Therapy Market, By Therapy Type; 3.3.3.4.2 Italy T-cell Therapy Market, By Indication; 3.3.3.5 Spain; 3.3.3.5.1 Spain T-cell Therapy Market, By Therapy Type; 3.3.3.5.2 Spain T-cell Therapy Market, By Indication; 3.3.3.6 Rest of Europe; 3.3.3.6.1 Rest of Europe T-cell Therapy Market, By Therapy Type; 3.3.3.6.2 Rest of Europe T-cell Therapy Market, By Indication; 3.4. Asia-Pacific; 3.4.1 Asia-Pacific T-cell Therapy Market, By Therapy Type; 3.4.2 Asia-Pacific T-cell Therapy Market, By Indication; 3.4.3 Asia-Pacific T-cell Therapy Market, By Country; 3.4.3.1 China; 3.4.3.1.1 China T-cell Therapy Market, By Therapy Type; 3.4.3.1.2 China T-cell Therapy Market, By Indication; 3.4.3.2 Japan; 3.4.3.2.1 Japan T-cell Therapy Market, By Therapy Type; 3.4.3.2.2 Japan T-cell Therapy Market, By Indication; 3.4.3.3 India; 3.4.3.3.1 India T-cell Therapy Market, By Therapy Type; 3.4.3.3.2 India T-cell Therapy Market, By Indication; 3.4.3.4 Singapore; 3.4.3.4.1 Singapore T-cell Therapy Market, By Therapy Type; 3.4.3.4.2 Singapore T-cell Therapy Market, By Indication; 3.4.3.5 Rest of Asia; 3.4.3.5.1 Rest of Asia T-cell Therapy Market, By Therapy Type; 3.4.3.5.2 Rest of Asia T-cell Therapy Market, By Indication; 3.5. Rest of World; 3.5.1 Rest of World T-cell Therapy Market, By Therapy Type; 3.5.2 Rest of World T-cell Therapy Market, By Indication; 3.5.3 Rest of World T-cell Therapy Market, By Country; 3.5.3.1 South Africa; 3.5.3.1.1 South Africa T-cell Therapy Market, By Therapy Type; 3.5.3.1.2 South Africa T-cell Therapy Market, By Indication; 3.5.3.2 ROW Countries; 3.5.3.2.1 ROW Countries T-cell Therapy Market, By Therapy Type; 3.5.3.2.2 ROW Countries T-cell Therapy Market, By Indication; ROW Countries T-cell Therapy Market Value, By Indication, 2022-2031, Million USD LIST OF TABLES; TABLE 1. Global T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 2. CAR T-cell Therapy Market Value, By Region, 2022-2031, Million USD; TABLE 3. North America CAR T-cell Therapy Market Value, By Country, 2022-2031, Million USD; TABLE 4. Europe CAR T-cell Therapy Market Value, By Country, 2022-2031, Million USD; TABLE 5. Asia-Pacific CAR T-cell Therapy Market Value, By Country, 2022-2031, Million USD; TABLE 6. Rest of World CAR T-cell Therapy Market Value, By Country, 2022-2031, Million USD; TABLE 7. T Cell Receptor (TCR)-based Market Value, By Region, 2022-2031, Million USD; TABLE 8. North America T Cell Receptor (TCR)-based Market Value, By Country, 2022-2031, Million USD; TABLE 9. Europe T Cell Receptor (TCR)-based Market Value, By Country, 2022-2031, Million USD; TABLE 10. Asia-Pacific T Cell Receptor (TCR)-based Market Value, By Country, 2022-2031, Million USD; TABLE 11. Rest of World T Cell Receptor (TCR)-based Market Value, By Country, 2022-2031, Million USD; TABLE 12. Tumor Infiltrating Lymphocytes (TIL)-based Market Value, By Region, 2022-2031, Million USD; TABLE 13. North America Tumor Infiltrating Lymphocytes (TIL)-based Market Value, By Country, 2022-2031, Million USD; TABLE 14. Europe Tumor Infiltrating Lymphocytes (TIL)-based Market Value, By Country, 2022-2031, Million USD; TABLE 15. Asia-Pacific Tumor Infiltrating Lymphocytes (TIL)-based Market Value, By Country, 2022-2031, Million USD; TABLE 16. Rest of World Tumor Infiltrating Lymphocytes (TIL)-based Market Value, By Country, 2022-2031, Million USD; TABLE 17. Global T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; TABLE 18. Hematologic Malignancies Market Value, By Region, 2022-2031, Million USD; TABLE 19. North America Hematologic Malignancies Market Value, By Country, 2022-2031, Million USD; TABLE 20. Europe Hematologic Malignancies Market Value, By Country, 2022-2031, Million USD; TABLE 21. Asia-Pacific Hematologic Malignancies Market Value, By Country, 2022-2031, Million USD; TABLE 22. Rest of World Hematologic Malignancies Market Value, By Country, 2022-2031, Million USD; TABLE 23. Solid Tumors Market Value, By Region, 2022-2031, Million USD; TABLE 24. North America Solid Tumors Market Value, By Country, 2022-2031, Million USD; TABLE 25. Europe Solid Tumors Market Value, By Country, 2022-2031, Million USD; TABLE 26. Asia-Pacific Solid Tumors Market Value, By Country, 2022-2031, Million USD; TABLE 27. Rest of World Solid Tumors Market Value, By Country, 2022-2031, Million USD; TABLE 28. Other Indications Market Value, By Region, 2022-2031, Million USD; TABLE 29. North America Other Indications Market Value, By Country, 2022-2031, Million USD; TABLE 30. Europe Other Indications Market Value, By Country, 2022-2031, Million USD; TABLE 31. Asia-Pacific Other Indications Market Value, By Country, 2022-2031, Million USD; TABLE 32. Rest of World Other Indications Market Value, By Country, 2022-2031, Million USD; TABLE 33. Global T-cell Therapy Market Value, By Region, 2022-2031, Million USD; TABLE 34. North America T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 35. North America T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; TABLE 36. North America T-cell Therapy Market Value, By Country, 2022-2031, Million USD; TABLE 37. U.S. T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 38. U.S. T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; TABLE 39. Canada T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 40. Canada T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; TABLE 41. Europe T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 42. Europe T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; TABLE 43. Europe T-cell Therapy Market Value, By Country, 2022-2031, Million USD; TABLE 44. Germany T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 45. Germany T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; TABLE 46. U.K. T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 47. U.K. T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; TABLE 48. France T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 49. France T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; TABLE 50. Italy T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 51. Italy T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; TABLE 52. Spain T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 53. Spain T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; TABLE 54. Rest of Europe T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 55. Rest of Europe T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; TABLE 56. Asia-Pacific T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 57. Asia-Pacific T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; TABLE 58. Asia-Pacific T-cell Therapy Market Value, By Country, 2022-2031, Million USD; TABLE 59. China T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 60. China T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; TABLE 61. Japan T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 62. Japan T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; TABLE 63. India T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 64. India T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; TABLE 65. Singapore T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 66. Singapore T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; TABLE 67. Rest of Asia T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 68. Rest of Asia T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; TABLE 69. Rest of World T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 70. Rest of World T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; TABLE 71. Rest of World T-cell Therapy Market Value, By Country, 2022-2031, Million USD; TABLE 72. South Africa T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 73. South Africa T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; TABLE 74. ROW Countries T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD; TABLE 75. ROW Countries T-cell Therapy Market Value, By Indication, 2022-2031, Million USD; ROW Countries T-cell Therapy Market Value, By Indication, 2022-2031, Million USD